PPT-Respecting the Burden of Adherence

Ronni AW Wetmore RN MS Coordinator Stanford Adult Cystic Fibrosis Center Speaker Bureau Chiesi Pharmaceuticals Nurse Advisory Board Genentech Pharmaceutical Company Nurse Advisory Board Gilead Pharmaceutical. Doyle M. Cummings, PharmD, FCP, FCCP. Professor of Family Medicine and Public Health. East Carolina University, Brody School of Medicine. Greenville, North Carolina. . [Residency educators may . adapt and use . www.YourDiabetesInfo.org/MedicationAdherence. . Medication Adherence: Resources for Patients. Medication Adherence: Resources for Health Care Teams. Medication Adherence: Scientific Evidence. Criteria For Inclusion. Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Reasons for non-adherence: cognitive rational non-adherence. Adherence is all about being conscientious in following medical advice. . Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Adherence is all about being conscientious in following medical advice. . This . section looks specifically at following recommendations for taking . Jessica Haberer, MD, MS. July . 24, . 2017. Conflicts of Interest. I have no conflicts to declare. Grant funding: US National Institutes of Health, Bill and Melinda Gates Foundation, USAID. Consultation: US National Institutes of Health, World Health Organization, Merck. Angelica Lindsey-Ali & Calicia White. Ebony House Inc.. Objectives. By the end of this section, participants should be able to. : . Understand the difference between cultural humility and cultural competence. B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Bukusi. . Kenya Medical Research Institute. University of Washington. University of California, San Franscisco . . Adherence crucial for success of any clinical drug trial and/or treatment. Ronni. AW Wetmore, RN, MS. Coordinator, Stanford Adult Cystic Fibrosis Center. Speaker Bureau: . Chiesi. Pharmaceuticals. Nurse Advisory Board: Genentech Pharmaceutical Company. Nurse Advisory Board: Gilead Pharmaceutical. What you need to learn?. Definition of patient medication adherence. Consequences of patient non adherence. Types of non adherence. Causes for non adherence. How to measure medication non adherence. Methods to improve adherence. Patients do . not. take their medicine . as prescribed. about . half. the time. . 2. Why is it important to assess adherence?. =. 3. 4. Eight. . steps to . improve medication adherence. in . your. Dr. Seema Sahay, Ph.D. Division of Social and Behavioral Research. National AIDS Research Institute. Indian Council of Medical Research, Pune (India). Overview. Defining and measuring adherence. Issues around adherence. Ira Wilson, MD, . MSc. 1. Conflicts of Interest. Dr. Wilson has no conflicts . of interest. 2. Goals: 4 Questions. Is provider-patient. communication really that important in adherence?. What is the quality of adherence related communication?. EPF Position Paper March 2015 2 Adherence and Concordance EPF position paper , March 2015 Contents 1 Introduction ................................ ................................ ....................